These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12367647)

  • 1. Chronic human parvovirus B19 infection in rheumatic disease of childhood and adolescence.
    Lehmann HW; Kühner L; Beckenlehner K; Müller-Godeffroy E; Heide KG; Küster RM; Modrow S
    J Clin Virol; 2002 Aug; 25(2):135-43. PubMed ID: 12367647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
    Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
    Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
    Lehmann HW; Knöll A; Küster RM; Modrow S
    Arthritis Rheum; 2003 Jun; 48(6):1631-8. PubMed ID: 12794831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women.
    Hemauer A; Gigler A; Searle K; Beckenlehner K; Raab U; Broliden K; Wolf H; Enders G; Modrow S
    J Med Virol; 2000 Jan; 60(1):48-55. PubMed ID: 10568763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
    Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
    J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses in parvovirus B19 infected patients.
    Modrow S; Dorsch S
    Pathol Biol (Paris); 2002 Jun; 50(5):326-31. PubMed ID: 12116851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
    Heegaard ED; Rasksen CJ; Christensen J
    J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of parvovirus B19-specific antibodies and of viral DNA in patients with endogenous uveitis.
    Heinz C; Plentz A; Bauer D; Heiligenhaus A; Modrow S
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):999-1004. PubMed ID: 15906067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term follow up of serostatus after maternofetal parvovirus B19 infection.
    Dembinski J; Eis-Hübinger AM; Maar J; Schild R; Bartmann P
    Arch Dis Child; 2003 Mar; 88(3):219-21. PubMed ID: 12598382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins.
    Manaresi E; Zuffi E; Gallinella G; Gentilomi G; Zerbini M; Musiani M
    J Med Virol; 2001 May; 64(1):67-73. PubMed ID: 11285571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent parvovirus B19 infections in immunocompromised children.
    Flunker G; Peters A; Wiersbitzky S; Modrow S; Seidel W
    Med Microbiol Immunol; 1998 Mar; 186(4):189-94. PubMed ID: 9574901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
    Beersma MF; Claas EC; Sopaheluakan T; Kroes AC
    J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis.
    Zakrzewska K; Azzi A; De Biasi E; Radossi P; De Santis R; Davoli PG; Tagariello G
    J Med Virol; 2001 Oct; 65(2):402-7. PubMed ID: 11536251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG.
    Kerr S; O'Keeffe G; Kilty C; Doyle S
    J Med Virol; 1999 Feb; 57(2):179-85. PubMed ID: 9892405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired gamma interferon responses against parvovirus B19 by recently infected children.
    Corcoran A; Doyle S; Waldron D; Nicholson A; Mahon BP
    J Virol; 2000 Nov; 74(21):9903-10. PubMed ID: 11024117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of functional B cell memory against parvovirus B19 capsid proteins may be associated with resolution of persistent infection.
    Corcoran A; Crowley B; Dewhurst C; Pizer BL; Doyle S
    J Med Virol; 2006 Jan; 78(1):125-8. PubMed ID: 16299723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-VP1 and anti-VP2 antibodies detected by immunofluorescence assays in patients with acute human parvovirus B19 infection.
    Pereira RF; Paula WN; Cubel Rde C; Nascimento JP
    Mem Inst Oswaldo Cruz; 2001 May; 96(4):507-13. PubMed ID: 11391423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baculovirus expression of parvovirus B19 (B19V) NS1: utility in confirming recent infection.
    Ennis O; Corcoran A; Kavanagh K; Mahon BP; Doyle S
    J Clin Virol; 2001 Aug; 22(1):55-60. PubMed ID: 11418353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping of B-cell epitopes on human parvovirus B19 non-structural and structural proteins.
    Tolfvenstam T; Lundqvist A; Levi M; Wahren B; Broliden K
    Vaccine; 2000 Nov; 19(7-8):758-63. PubMed ID: 11115697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection.
    Jones LP; Erdman DD; Anderson LJ
    J Infect Dis; 1999 Aug; 180(2):500-4. PubMed ID: 10395869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.